Explore by Category
IMW: Defining High Risk Multiple Myeloma Today and Into the Future
MYELOMA NEWS - September 09, 2021
At the International Myeloma Workshop in Vienna, French researcher Herve Avet-Louiseu, MD, PhD shared a presentation about how he sees high risk myeloma to... Read More
The International Myeloma Workshop Opens in Vienna
MYELOMA NEWS - September 08, 2021
“Just imagine what we will see as we move these therapies up front,” pondered International Myeloma Society (IMS) President Nikhil Munshi about... Read More
FDA Clears Application for First Off-the-Shelf CAR T in Multiple Myeloma
MYELOMA NEWS - September 02, 2021
The first off-the-shelf CAR T targeting BCMA has received FDA clearance to begin clinical trials. This week the FDA approved an investigational new drug applica... Read More
FDA Grants Orphan Disease Designation for Multiple Myeloma Oral IKZF1/3 Inhibitor
MYELOMA NEWS - August 19, 2021
A new class of drug that selectively destroys myeloma-causing proteins through degradation has received Orphan Disease Designation from the FDA for multiple mye... Read More
FDA Approves Booster COVID Shot for Immunocompromised Individuals
MYELOMA NEWS - August 16, 2021
Last week the U.S. Food and Drug Administration approved the use of a third booster shot of either the Pfizer-BioNTech or Moderna COVID0-19 vaccine for immunoco... Read More
FDA Approval for Shingrix to Prevent Shingles Post Auto Stem Cell Transplant Transplant in Multiple Myeloma
MYELOMA NEWS - August 09, 2021
The title of this article actually short-changes the recent supplemental FDA approval of Shingrix, and I would like to rectify that right away. The full supplem... Read More
Darzalex FasPro Receives FDA Approval for Use with Pomalidomide and Dex in Multiple Myeloma
MYELOMA NEWS - August 04, 2021
Darzalex Faspro, the subcutaneous 5 minute shot version of daratumumab, has been FDA approved for use with pomalidomide and dexamethasone for multiple myeloma p... Read More
Response Rate and Response Predictors to the Pfizer/BioNTech Vaccine in Multiple Myeloma Patients
MYELOMA NEWS - August 04, 2021
There are currently three Covid-19 vaccines (Pfizer/BioNTech, Moderna, Johnson & Johnson) approved by the US Food and Drug Administration for emergency use ... Read More
Using A Simple Test Called Mass-Fix to Predict Multiple Myeloma Survival
MYELOMA NEWS - August 03, 2021
A new blood-based, inexpensive test could help predict survival for multiple myeloma patients. The Mass-Fix test was created by the Mayo Clinic. We... Read More
What to Pair with Bispecific Antibodies in Multiple Myeloma
MYELOMA NEWS - August 02, 2021
A significant number of bispecific antibodies are being developed for multiple myeloma, going after a variety of targets including BCMA. The bispecific antibodi... Read More
FDA Alert for Pepaxto (melflufen) in Multiple Myeloma
MYELOMA NEWS - July 29, 2021
The Myeloma Crowd by HealthTree occasionally posts results of clinical studies of interest to our family of myeloma patients and caregivers. Myeloma trials... Read More
Fresh Hope for Those With Chronic Graft vs. Host Disease
MYELOMA NEWS - July 28, 2021
Chronic graft versus host disease (cGvHD) is a complication that can occur in about 50% of patients following allo-stem cell transplant. Most cases are mild to ... Read More
Iberdomide: A Potent New Drug to Treat Revlimid/Pomalyst Resistant Myeloma
MYELOMA NEWS - July 07, 2021
Most multiple myeloma patients will take Revlimid or Pomalyst at some point in their treatment, but many patients can become resistant to these immunomodulators... Read More
. 
